Publication:
aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease

dc.contributor.authorIsik, A. T.
dc.contributor.authorBozoglu, E.
dc.contributor.authorEker, D.
dc.date.accessioned2020-10-29T17:18:34Z
dc.date.available2020-10-29T17:18:34Z
dc.date.issued2012-02-01T00:00:00Z
dc.description.abstractInsulin resistance (IR) may play a role in most pathogenic processes that promote the development of Late Onset Alzheimer Disease (LOAD). This study was designed to determine the interaction between inhibition of both butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) with rivastigmine and peripheral insulin resistance (IR) in LOAD.
dc.identifier.citationIsik A. T. , Bozoglu E., Eker D., -aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease-, JOURNAL OF NUTRITION HEALTH & AGING, cilt.16, ss.139-141, 2012
dc.identifier.doi10.1007/s12603-011-0095-4
dc.identifier.pubmed22323348
dc.identifier.scopus84863488169
dc.identifier.urihttp://hdl.handle.net/20.500.12645/25662
dc.identifier.wosWOS:000301189000005
dc.titleaChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease
dc.typeArticle
dspace.entity.typePublication
local.avesis.id3b91d776-d5f6-4c13-8cd3-47743943c1ec
local.indexed.atPubMed
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1

Files